dalteparin has been researched along with Embryopathies in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yurttutan, S | 1 |
| Ozdemir, R | 1 |
| Erdeve, O | 1 |
| Calisici, E | 1 |
| Oncel, MY | 1 |
| Oguz, SS | 1 |
| Dilmen, U | 1 |
1 other study available for dalteparin and Embryopathies
| Article | Year |
|---|---|
Intrauterine upper extremity thrombosis successfully treated with recombinant tissue plasminogen activator, enoxaparin and collagenase.
Topics: Collagenases; Enoxaparin; Fetal Diseases; Fibrinolytic Agents; Humans; Infant, Newborn; Male; Necros | 2012 |